Metabolic syndrome in association with novel dietary index, metabolic parameters, nesfatin-1 and omentin-1

BMC Endocrine Disorders

Table 3 The comparison of biochemical variables of study participants across CPI tertiles

Variable	All participants		Tertiles of CPI						P Value	P* values
	All participants		T₁		T₂		T₃		P Value
	Mean	SD	Mean		Mean	SD	Mean	SD
FBS (mg/dl)	92.66	19.18	88.50	4.83	93.23	25.74	91.32	14.27	0.154	0.098
Insulin (mIU/l)	16.17	13.66	15.60	6.32	15.09	8.00	16.94	16.66	0.580	0.075
HOMA-IR	3.76	3.26	3.35	1.35	3.66	2.44	3.85	3.78	0.874	0.075
SBP (mmHg)	122.99	16.35	134.00	19.55	119.41	16.99	124.61	15.38	0.002	< 0.001
DBP (mmHg)	81.78	11.69	86.00	8.75	79.39	13.13	83.00	10.65	0.012	0.002
LDL (mg/dl)	123.68	31.83	127.04	25.26	117.20	29.70	117.41	32.82	0.016	0.176
HDL (mg/dl)	43.32	9.52	39.70	11.92	44.88	9.44	42.57	9.35	0.046	0.001
TG (mg/dl)	152.55	94.13	224.40	91.20	136.57	99.52	158.71	88.91	0.005	0.010
TC (mg/dl)	191.45	36.64	184.90	29.95	186.91	32.47	194.49	39.02	0.158	0.097
Nesfatin-1 (ng/ml)	3.5	1.12	2.5	0.23	3.29	0.88	3.71	1.26	0.029	0.040
Omentin-1 (ng/ml)	6.20	1.41	3.33	1.00	6.13	1.296	6.54	1.21	< 0.001	< 0.001

CPI, cardioprotective index; SD, standard deviation; FBS, fasting blood sugar; HOMA-IR, homeostatic model assessment for insulin resistance; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol; TG, triglyceride; TC, total cholesterol; P values derived from unadjusted ANOVA. P* values derived from general linear model (GLM) after adjustment for confounders (age, gender, BMI, PA and energy intake)

ISSN: 1472-6823